Ag Biotech Entrepreneurial Showcase 2015

Posted by on Jan 29, 2015 in Newsroom | 0 comments

Join the largest gathering of ag technologies and investors in the Eastern U.S. You’ll also see tech scouts from the global ag biotech companies. Apply now. Deadline is Feb. 12.  Program Agenda will include: Entrepreneurial presentations Panel sessions Keynote speakers Application to Present Register Registration opens March 23. Early Bird (ends Apr. 28) $75 Regular (Apr. 29) $100 About This event drives commercialization by showcasing investment-ready ag technologies. Attendees include investors, tech scouts and researchers. 2014 Highlights 2013 Highlights - See more at:...

Read More

Special FDA designation puts more wind behind BioCryst’s sails

Posted by on Jan 26, 2015 in Newsroom | 0 comments

DURHAM, N.C. – Shares of Durham’s BioCryst Pharmaceuticals (Nasdaq: BCRX) traded up nearly 4 percent pre-market on news that it received Fast Track designation for its experimental treatment for hereditary angioedema. The designation awarded by the U.S. Food and Drug Administration means the drug developer can move the drug called BCX4161 through the development process faster, ideally bringing the drug to market sooner, meaning BioCryst can make money faster. A drug that receives Fast Track designation is usually eligible for more frequent written communication and meetings with...

Read More

N.C. drug company raises $37M for migraine treatment

Posted by on Jan 18, 2015 in Newsroom | 0 comments

DURHAM, N.C. – CoLucid Pharmaceuticals raised $37 million to continue development of a drug for migraines and headache pain. It’s an important area of need. Some 36 million people suffer from migraines – or more than those who have asthma or diabetes combined. Migraine is ranked as the seventh highest cause of global disability and is one of the top 10 causes of disability in 14 of 21 world regions studied, according to findings by the Global Burden of Disease Survey 2010 conducted by the World Health Organization. It is the leading cause of disability among neurological...

Read More

Biotech center extends loan to Morrisville eye imaging tech concern

Posted by on Jan 18, 2015 in Newsroom | 0 comments

MORRISVILLE, N.C. – Bioptigen, which already has one eye-scanning device on the market, is in the middle of developing a second such device to be used in eye surgeries. To help fund development, the N.C. Biotechnology Center kicked in a $458,000 in a loan. The Biotech Center serves as an economic developer and resource for small companies in North Carolina’s life sciences industries . The group, led by CEO Doug Edgeton, uses state tax money to extend grants or loans to small North Carolina life sciences companies who can’t find investments elsewhere, often because they need...

Read More

Dignify Therapeutics Awarded $250,000 NCBiotech Loan for Bladder, Bowel Therapy

Posted by on Jan 13, 2015 in Newsroom | 0 comments

RESEARCH TRIANGLE PARK, N.C. – Dignify Therapeutics LLC, a drug development company focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions, has received a $250,000 Small Business Research Loan (SRL) from the North Carolina Biotechnology Center.  The loan supports preclinical development of Dignify’s lead product, DTI-100, in preparation for a Phase I clinical study planned for 2015. Dignify is developing novel pharmaceutical treatments for bladder and bowel dysfunction which will significantly improve the quality...

Read More

RTP drug startup Dignify Therapeutics lands $330,000 Biotech Center loans

Posted by on Jan 7, 2015 in Newsroom | 0 comments

RESEARCH TRIANGLE PARK, N.C. – The North Carolina Biotechnology Center has awarded two loans in two years totaling $300,000 to help propel a young Research Triangle Park drug company with a unique product line: Dignify Therapeutics. Dignify’s lead product, DTI-100, is believed to be the only medication ever designed specifically to provide rapid, on-demand, drug-induced voiding as a therapeutic strategy. The object is to provide a form of bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions. NCBiotech recently awarded Dignify a...

Read More